(NBS:Consolidated Issue listed on NASDAQ Capital Market)
Robin L. Smith M.D., MBA,Ro
Executive Chairman, Neostem, Inc.
|Age||Total Calculated Compensation||This person is connected to 73 board members in 8 different organizations across 9 different industries.|
See Board Relationships
As of Fiscal Year 2013
Dr. Robin L. Smith, M.D., MBA, Ro, has been Executive Chairman of Neostem, Inc. and served as its and Chief Executive Officer since June 2, 2006. Dr. Smith served as the Chief Operating Officer - Ip2m Division and Senior Vice President - Ip2m Division at Dialog Group, Inc. Dr. Smith serves as Member of Advisory Board at Wellfleet Partners Investment Arm. They serves as Member of Medical Advisory Board at House of Brussels Chocolates Inc. He serves as Member of Advisory ...
420 Lexington AvenuePhone: 212-584-4180
New York, New York 10170
Board Members Memberships*
Director, Chairman of Compensation Committee, Member of Audit Committee and Member of Nominating & Governance Committee
University of Pennsylvania - The Wharton School
|Dominick C. Colangelo Esq.||Chief Executive Officer, President, Treasurer and Director|
|Gil Van Bokkelen Ph.D.||Co-Founder, Chairman and Chief Executive Officer|
|Robin C. Stracey||Interim Chief Executive Officer, Director, Chairman of Compensation Committee, Member of Audit Committee and Member of Governance & Nominating Committee|
Cesca Therapeutics Inc.
|Marc H. Hedrick M.D.||Chief Executive Officer, President and Director|
Cytori Therapeutics, Inc.
|Martin P. Rosendale||Chief Executive Officer and Director|
Nuo Therapeutics, Inc.
|$467.3K||Compensation as of Fiscal Year 2013.|